Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients

The mineralocorticoid receptor antagonist spironolactone has been shown to improve cardiac function and reverse left ventricular hypertrophy in heart failure patients, but there are no consistent findings on the efficacy and safety in hemodialysis patients. Abnormal aldosterone secretion plays a cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zuoya, Chen, Zhiyuan, Liu, Ruihong, Lu, Gang, Li, Zhuo, Sun, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882618/
https://www.ncbi.nlm.nih.gov/pubmed/36712946
http://dx.doi.org/10.2147/DDDT.S393480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882618/
https://www.ncbi.nlm.nih.gov/pubmed/36712946
http://dx.doi.org/10.2147/DDDT.S393480

Ejemplares similares